Health
Penn Study Finds Solid-Tumor Cancer Patients Ineligible for Clinical Trials Receive Immunotherapy at Greater Rates Despite Lack of Benefits – pennmedicine.org
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients…
PHILADELPHIA — Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the Perelman School…
Continue Reading
-
Noosa News24 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
General16 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
General20 hours agoIndia to defend ‘red lines’ as fresh tariffs loom
-
Noosa News22 hours agoDance Nation shows the messy truth of adolescent dance comps